UNITED STATES
                        SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549

                                     FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934


                         Date of Report: March 28, 2005
                        --------------------------------
                        (Date of earliest event reported)


                              OSK CAPITAL III CORP.
                      ------------------------------------
             (Exact name of registrant as specified in its charter)


               COLORADO           000-30023              84-1491676
               -------            ---------             ----------
              State of           Commission            IRS Employer
           incorporation         File Number       Identification Number

                               1 Place Ville-Marie
                                   Suite 2821
                                  Montreal, Qc
                                     H3B 4R4
             -------------------------------------------------------
                    (Address of principal executive offices)

                                Tel: 514-448-6710
                              --------------------
                           (Issuer's telephone number)

                      P. O. Box 461029, Glendale, CO 80220
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)

Copies of all communications, including all communications sent to the agent for
service

Copies of all communications, including all communications sent to the agent for
service, should be sent to:

                              Joseph I. Emas, Esq.
                                 Attorney at Law
                             1224 Washington Avenue
                              Miami Beach, FL 33139

<PAGE>

ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS.

On March 14, 2005, we completed our  acquisition  of Ideal Medical Inc., a Texas
corporation,  pursuant to an Agreement and Plan of Merger,  the form of which is
attached as Exhibit  2.1  hereto.  At the  effective  time of the merger,  Ideal
Medical  Inc.  will be merged  with and into our wholly  owned  subsidiary,  OSK
Acquisition Corp., a Florida corporation,  which will be subsequently  dissolved
and merged into our company.  On March 28, 2005, we determined  that the Closing
Date shall be March 30, 2005.

All of the  outstanding  shares of Ideal  Medical  Inc.  common  stock  shall be
converted  by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities").  On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding  shares
of Ideal Medical Inc.  common stock  existing  immediately  prior to the Closing
Date. Until so surrendered,  any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such  surrender,  shares of Ideal Medical Inc.  common stock so surrendered
shall no longer be outstanding and shall  automatically  be canceled and retired
and shall cease to exist.

The  foregoing  description  of the Agreement and Plan of Merger is qualified in
its entirety by reference to the Agreement and Plan of Merger, the form of which
is attached as Exhibit 2.1 hereto and incorporated herein by reference.
This report  contains  forward-looking  statements as the term is defined in the
Private  Securities  Litigation  Reform Act of 1995. These statements  relate to
future  events or our  future  financial  performance.  In some  cases,  you can
identify  forward-looking  statements  by  terminology  such as  "may",  "will",
"should",   "expects",   "plans",   "anticipates",    "believes",   "estimates",
"predicts",  "potential"  or  "continue" or the negative of these terms or other
comparable terminology.  These statements are only predictions and involve known
and unknown risks, uncertainties and other factors.  Therefore,  actual outcomes
and results may differ  materially  from what is  expressed  or forecast in such
forward-looking  statements.  For a list  and  descriptions  of such  risks  and
uncertainties,  see the reports  filed by us with the  Securities  and  Exchange
Commission.

<PAGE>

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(a)   Financial statements of business acquired.

The financial  statements  required by this Item 9(a) will be filed by amendment
to this Form 8-K within the period permitted by Item 9(a)(4) of Form 8-K.

(b) Pro Forma financial information

The pro forma financial  information required by this Item 9(b) will be filed by
amendment  to this Form 8-K within the period  permitted by Item 9(a)(4) of Form
8-K.

(c)  Exhibits

     Exhibits     Description
     --------     -----------

       2.1        Agreement and Plan of Merger by and between Ideal Medical Inc,
                  OSK Acquisition Corp. and OSK Capital III, Corp., dated March
                  14, 2005.



                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undesigned hereunto duly authorized.

                                OSK CAPITAL III CORP.


DATE: March 28, 2005            /s/ Francis Mailhot
                                ------------------------
                                Francis  Mailhot  President,  CEO and Chairman
                                OSK CAPITAL III CORP.
{"company-data": {"conformed-name": "OSK CAPITAL III CORP", "cik": "0001107565", "assigned-sic": "9995", "irs-number": "841491676", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-30023", "film-number": "05705814"}, "business-address": {"street1": "4750 TABLE MESA DR", "city": "BOULDER", "state": "CO", "zip": "80303", "phone": "3034943000"}, "mail-address": {"street1": "4750 TABLE MESA DR", "city": "BOULDER", "state": "CO", "zip": "80303"}}
UNITED STATES
                        SECURITIES AND EXCHANGE COMMISSION
                               Washington, D.C. 20549

                                     FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

                         Date of Report: March 28, 2005
                        --------------------------------
                        (Date of earliest event reported)

                              OSK CAPITAL III CORP.
                      ------------------------------------
             (Exact name of registrant as specified in its charter)

               COLORADO           000-30023              84-1491676
               -------            ---------             ----------
              State of           Commission            IRS Employer
           incorporation         File Number       Identification Number

                               1 Place Ville-Marie
                                   Suite 2821
                                  Montreal, Qc
                                     H3B 4R4
             -------------------------------------------------------
                    (Address of principal executive offices)

                                Tel: 514-448-6710
                              --------------------
                           (Issuer's telephone number)

                      P. O. Box 461029, Glendale, CO 80220
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)

Copies of all communications, including all communications sent to the agent for
service

Copies of all communications, including all communications sent to the agent for
service, should be sent to:

                              Joseph I. Emas, Esq.
                                 Attorney at Law
                             1224 Washington Avenue
                              Miami Beach, FL 33139
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS.

On March 14, 2005, we completed our  acquisition  of Ideal Medical Inc., a Texas
corporation,  pursuant to an Agreement and Plan of Merger,  the form of which is
attached as Exhibit  2.1  hereto.  At the  effective  time of the merger,  Ideal
Medical  Inc.  will be merged  with and into our wholly  owned  subsidiary,  OSK
Acquisition Corp., a Florida corporation,  which will be subsequently  dissolved
and merged into our company.  On March 28, 2005, we determined  that the Closing
Date shall be March 30, 2005.

All of the  outstanding  shares of Ideal  Medical  Inc.  common  stock  shall be
converted  by virtue of the merger at the Closing Date into shares of our common
stock (the "Merger Securities").  On or before the Closing Date, March 30, 2005,
each Shareholder of Ideal Medical Inc. shall surrender their outstanding  shares
of Ideal Medical Inc.  common stock  existing  immediately  prior to the Closing
Date. Until so surrendered,  any outstanding certificates or other documentation
which, prior to the Closing Date represented outstanding shares of Ideal Medical
Inc. common stock, shall be deemed for all corporate purposes to be surrendered.
Upon such  surrender,  shares of Ideal Medical Inc.  common stock so surrendered
shall no longer be outstanding and shall  automatically  be canceled and retired
and shall cease to exist.

The  foregoing  description  of the Agreement and Plan of Merger is qualified in
its entirety by reference to the Agreement and Plan of Merger, the form of which
is attached as Exhibit 2.1 hereto and incorporated herein by reference.
This report  contains  forward-looking  statements as the term is defined in the
Private  Securities  Litigation  Reform Act of 1995. These statements  relate to
future  events or our  future  financial  performance.  In some  cases,  you can
identify  forward-looking  statements  by  terminology  such as  "may",  "will",
"should",   "expects",   "plans",   "anticipates",    "believes",   "estimates",
"predicts",  "potential"  or  "continue" or the negative of these terms or other
comparable terminology.  These statements are only predictions and involve known
and unknown risks, uncertainties and other factors.  Therefore,  actual outcomes
and results may differ  materially  from what is  expressed  or forecast in such
forward-looking  statements.  For a list  and  descriptions  of such  risks  and
uncertainties,  see the reports  filed by us with the  Securities  and  Exchange
Commission.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

(a)   Financial statements of business acquired.

The financial  statements  required by this Item 9(a) will be filed by amendment
to this Form 8-K within the period permitted by Item 9(a)(4) of Form 8-K.

(b) Pro Forma financial information

The pro forma financial  information required by this Item 9(b) will be filed by
amendment  to this Form 8-K within the period  permitted by Item 9(a)(4) of Form
8-K.

(c)  Exhibits

     Exhibits     Description
     --------     -----------

       2.1        Agreement and Plan of Merger by and between Ideal Medical Inc,
                  OSK Acquisition Corp. and OSK Capital III, Corp., dated March
                  14, 2005.

                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undesigned hereunto duly authorized.

                                OSK CAPITAL III CORP.

DATE: March 28, 2005            /s/ Francis Mailhot
                                ------------------------
                                Francis  Mailhot  President,  CEO and Chairman
                                OSK CAPITAL III CORP.